Document Detail

Transcriptomic profiling of the four adenosine receptors in human leukocytes of heart failure patients.
MedLine Citation:
PMID:  23936818     Owner:  NLM     Status:  In-Data-Review    
In this study the transcriptomic profiling of adenosine receptors (ARs) in human leukocytes of heart failure (HF) patients as a function of clinical severity, assessing the possible changes with respect to healthy subjects (C), was evaluated. Total RNA was extracted from leukocytes of C (n = 8) and of HF patients (NYHA I-II n = 9; NYHA III-IV n = 14) with a PAXgene Blood RNA Kit. An increase as a function of clinical severity was observed in each AR (A1R: C = 0.02 ± 0.009, NYHA I-II = 0.21 ± 0.09, NYHA III-IV = 3.6 ± 1.3, P = 0.03  C versus NYHA III-IV, P = 0.02 NYHA I-II versus NYHA III-IV; A2aR: C = 0.2 ± 0.05, NYHA I-II = 0.19 ± 0.04, NYHA III-IV = 1.32 ± 0.33, P = 0.005  C versus NYHA III-IV, P = 0.003 NYHA I-II versus NYHA III-IV; A2bR: C = 1.78 ± 0.36, NYHA I-II = 1.35 ± 0.29, NYHA III-IV = 4.07 ± 1.21, P = 0.03: NYHA I-II versus NYHA III-IV; A3R: C = 0.76 ± 0.21, NYHA I-II = 0.94 ± 0.19, NYHA III-IV = 3.14 ± 0.77, P = 0.01  C versus NYHA III-IV and NYHA I-II versus NYHA III-IV, resp.). The mRNA expression of the ectonucleoside triphosphate diphosphohydrolase (CD39) and the ecto-5'-nucleotidase (CD73) were also evaluated. They resulted up-regulated. These findings show that components of adenosine metabolism and signalling are altered to promote adenosine production and signalling in HF patients. Thus, HF may benefit from adenosine-based drug therapy after confirmation by clinical trials.
Manuela Cabiati; Raffaele Caruso; Alessandro Verde; Laura Sabatino; Maria-Aurora Morales; Silvia Del Ry
Related Documents :
2924778 - Incidence of arrhythmias after atrial or dual-chamber pacemaker implantation.
20639238 - Cerebrovascular accidents in adult patients with congenital heart disease.
2291308 - Venous function of the leg during atrial arrhythmias.
2107078 - Flecainide acetate in atrial flutter and fibrillation. the arrhythmogenic effects.
23176968 - Hepatotoxicity after transarterial chemoembolization and transjugular intrahepatic port...
11072938 - Secondary prevention with antioxidants of cardiovascular disease in endstage renal dise...
Publication Detail:
Type:  Journal Article     Date:  2013-07-08
Journal Detail:
Title:  BioMed research international     Volume:  2013     ISSN:  2314-6141     ISO Abbreviation:  Biomed Res Int     Publication Date:  2013  
Date Detail:
Created Date:  2013-08-12     Completed Date:  -     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  101600173     Medline TA:  Biomed Res Int     Country:  United States    
Other Details:
Languages:  eng     Pagination:  569438     Citation Subset:  IM    
Laboratory of Cardiovascular Biochemistry, CNR Institute of Clinical Physiology, Via Giuseppe Moruzzi 1, 56124 Pisa, Italy.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Leptin modulates norepinephrine-mediated melatonin synthesis in cultured rat pineal gland.
Next Document:  Ctla-4 expression and polymorphisms in lung tissue of patients with diagnosed non-small-cell lung ca...